Incidencia de neumonía en pacientes mayores de 60 años

Quiroz-Paguay, Inés Verónica; Gómez-Martínez, Nairovys; Donoso-Noroña, Riber Fabián; Vizuete, Elisabeth Germania Vilema

doi:10.35381/s.v.v6i2.2109

Vida y Salud

2022

DOI: 10.35381/s.v.v6i2.2109

|View full text |Cite

Incidencia de neumonía en pacientes mayores de 60 años

Inés Verónica Quiroz-Paguay

Nairovys Gómez-Martínez

Riber Fabián Donoso-Noroña

et al.

Abstract: Objetivo: Diagnosticar la incidencia de neumonía en pacientes mayores de 60 años de edad que ingresan al área de Medicina Interna del Hospital General Puyo. Método: Descriptiva observacional. Resultados: Los factores de riesgo de la neumonía, señalando que el 32% han presentado tabaquismo, el 25% alcoholismo, el 18% diabetes, el 11% enfermedades inmunológicas, el 7% son hipertensos y el 7% restante presentan enfermedades cardiovasculares. Conclusión: Se observó que los factores de riesgo con más prevalencia qu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Initial antimicrobial therapy and case fatality in patients with community-acquired pneumonia

Corona Martínez,

González Morales,

Fragoso Marchante

2023

IJMSS

View full text Add to dashboard Cite

The health importance of community-acquired pneumonia is an unquestionable fact given its relationship with hospital and overall mortality. The objective of the investigation was to evaluate the relationship between selected antimicrobials used in the initial treatment (amoxicillin/sulbactam, cefuroxime, ceftriaxone and cefotaxime) and mortality from pneumonia. An observational study was carried out, with a descriptive design and a population of 1,809 patients with pneumonia hospitalized between 2012 and 2019; the necessary information was obtained from the clinical history. Statistical processing was performed using bivariate and multivariate analysis (logistic regression); the ratio of cross products (odds ratio) and its 95% confidence interval were used as a statistician. Among the results, the following stand out: significantly higher lethality values were found in those treated with cefotaxime (33%) than in those who received amoxicillin/sulbactam (24%, OR 1.6[1.0001;2.6]), as well as in those treated with ceftriaxone (30%) compared with those treated with amoxicillin/sulbactam (24%, OR 1.3[1.05;1.8]) and with cefuroxime (24%, OR 1.3[1.04;1.7]). A higher frequency of patients with extensive pneumonia, of patients in a critical state on admission, and of bedridden occurrence during hospitalization were identified in those treated with cefotaxime. In patients with “moderate pneumonia and high probability of unfavorable outcome”, treatment with ceftriaxone or cefotaxime was associated with death; as well as ceftriaxone treatment for all subjects. It is concluded that the initial treatment with amoxicillin/ sulbactam or cefuroxime was more favorable than the use of third generation cephalosporins. Also in the global analysis, the absence of differences in lethality between those treated with amoxicillin/sulbactam and with cefuroxime was recognized.

show abstract

Initial antimicrobial therapy and case fatality in patients with community-acquired pneumonia

Corona Martínez,

González Morales,

Fragoso Marchante

2023

IJMSS

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Incidencia de neumonía en pacientes mayores de 60 años

Cited by 1 publication

References 3 publications

Initial antimicrobial therapy and case fatality in patients with community-acquired pneumonia

Initial antimicrobial therapy and case fatality in patients with community-acquired pneumonia

Contact Info

Product

Resources

About